Schedule 13D ownership disclosure

ACHILLION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00448Q201

Event date: 2014-09-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,363,507
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000904454-14-000629
Form type
SC 13D/A
Filer
ACHILLION PHARMACEUTICALS INC
CIK
CIK 1070336
Filed
Sep 11, 2014
Reporting period
Sep 09, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub